Guardion Health Sciences, Inc. (NASDAQ:GHSI) Short Interest Up 11.8% in March

Guardion Health Sciences, Inc. (NASDAQ:GHSI – Get Rating) was the target of a significant growth in short interest in March. As of March 31st, there was short interest totalling 140,600 shares, a growth of 11.8% from the March 15th total of 125,800 shares. Based on an average daily trading volume, of 27,900 shares, the days-to-cover ratio is presently 5.0 days. Approximately 11.5% of the shares of the stock are sold short.

Institutional Investors Weigh In On Guardion Health Sciences

An institutional investor recently bought a new position in Guardion Health Sciences stock. Millennium Management LLC purchased a new position in shares of Guardion Health Sciences, Inc. (NASDAQ:GHSI – Get Rating) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 365,783 shares of the company’s stock, valued at approximately $53,000. Millennium Management LLC owned approximately 0.60% of Guardion Health Sciences at the end of the most recent reporting period. 16.38% of the stock is owned by hedge funds and other institutional investors.

Guardion Health Sciences Price Performance

Shares of NASDAQ:GHSI opened at $6.34 on Friday. The company has a market capitalization of $8.05 million, a P/E ratio of -0.17 and a beta of 0.85. Guardion Health Sciences has a 1 year low of $4.66 and a 1 year high of $12.85. The business’s 50 day simple moving average is $6.13 and its 200 day simple moving average is $3.47.

Guardion Health Sciences Company Profile

Want More Great Investing Ideas?

(Get Rating)

Guardion Health Sciences, Incis a clinical nutrition and diagnostics company, which develops medical foods and medical devices in the ocular health space and develops nutraceutical products to provide supportive health benefits to consumers. The company was founded by Michael Favish in 2009 and is headquartered in Houston, TX.